Enhancing response to immunotherapy in urothelial carcinoma by targeted inhibition of the histone methyltransferase G9a pathway

Transl Androl Urol. 2019 Dec;8(Suppl 5):S469-S471. doi: 10.21037/tau.2019.10.07.
No abstract available

Publication types

  • Editorial
  • Comment